Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Diabetes

Journal Scan / Research · March 07, 2022

Efficacy of SGLT2 Inhibitors in Restoring Glucagon and Counterregulatory Hormone Response to Hypoglycemia in T1D

Diabetes

 

Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes
SGLT2 Inhibition Increases Fasting Glucagon but Does Not Restore the Counterregulatory Hormone Response to Hypoglycemia in Participants With Type 1 Diabetes
Diabetes 2022 Mar 01;71(3)511-519, SC Boeder, JM Gregory, ER Giovannetti, JH Pettus

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading